Rigel Pharmaceuticals Inc
RIGL
$46.75+3.64%
End of day · as of Aug 26, 2026, 4:11 AM ET
Mkt cap
$338.32M
EV/Sales
1.19
P/E ratio
N/A
FY2025 Revenue
$294.28M
EPS (TTM)
$16.89
Gross Margin (FY2025)
93.33%
Profit Margin (FY2025)
124.72%
Beta
1.29
Div yield
N/A
Sector
Healthcare
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported RIGL revenue for 2025-12-31 was $294.3M. Net income was $367.0M. Revenue was up 64.1% from 2024-12-31 to 2025-12-31. RIGL currently screens at market cap $338.3M.
Use this RIGL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RIGL income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company in the Healthcare sector.
Latest cached Rigel Pharmaceuticals Inc (RIGL) revenue for Dec 31, 2025 was $294.3M. Net income was $367.0M. Statements: https://lician.com/financials/rigl
Rigel Pharmaceuticals Inc (RIGL) market capitalization is $338.3M on the latest cached snapshot.
Rigel Pharmaceuticals Inc (RIGL) cached previous close $45.11; day range $45.14 – $47.46; volume 373,214. Session quote: https://lician.com/quote/rigl
Rigel Pharmaceuticals Inc (RIGL) latest cached earnings event is "RIGL earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RIGL filing is 8-K · Jul 1, 2026. Filings: https://lician.com/sec/rigl